scorecardresearch
Add as a preferred source on Google
Wednesday, November 19, 2025
TopicMRNA

Topic: mRNA

US gets 3rd vaccine against highly contagious Respiratory virus RSV. How India can benefit from these

Approval for Moderna’s mRESVIA is the 1st time an mRNA vaccine has been approved for a disease other than Covid. This could be crucial for India where RSV's a major public health challenge.

Nobel in Medicine 2023: How Katalin Karikó & Drew Weissman’s work helped save millions during pandemic

Hungarian biochemist Kariko & American immunologist Weismann won for research in mRNA, which enabled vaccine development for Covid. This followed decades of struggle.

After Covid, mRNA vaccine for cancer? US researchers report initial success against melanoma

Mice treated with the mRNA vaccine, delivered like ones for Covid, showed reduction in tumours & long-term immune memory, says study by Tufts University researchers published in PNAS.

Sputnik maker wages Twitter war over ‘low efficacy’ of mRNA vaccines, says its booster can help

Sputnik cites pre-print papers, claims its vaccine produces longer efficacy compared to mRNA vaccines like Pfizer or Moderna.

Delta variant may have led to reduced vaccine efficacy among US health workers, new study finds

Researchers at University of California San Diego Health find that vaccine efficacy in US health workers dipped from 90% to 65.5%, recommend continued use of masks & intensive testing.

Benefits of Covid vaccines outweigh risk of one-sided facial paralysis, Lancet study says

The researchers from University of Hong Kong also noted that the mechanism by which Covid vaccination can — in very rare instances — lead to the condition remains unclear.

Second mRNA vaccine shot safe for people who had allergic reactions to first shot: US study

Of the 189 patients who participated in the study, 130 received the Moderna vaccine, while 59 got the Pfizer-BioNTech vaccine. Second dose was administered to 159 subjects.

New Covid vaccine could make copies of itself in your body, protect you at very low doses

saRNA vaccines function similar to mRNA vaccines with the additional benefit of lowering dose requirements and making production more scalable.

mRNA vaccines could cause heart inflammation in rare cases, studies in JAMA suggest

According to the two studies, there is a link between mRNA-based vaccines and the heart condition myocarditis. But experts caution that the link between the two does not establish causality.

GlaxoSmithKline, CureVac team up to develop vaccines to tackle Covid variants

The immunisations may be used to protect people who haven’t been inoculated or as booster shots if immunity from other vaccines wanes.

On Camera

Why the US Congress put its foot down on releasing the Jeffrey Epstein files

The US House has effectively drawn a line in the sand and approved the release of the Epstein files despite President Trump's efforts to stop it from happening.

At Charcha 2025: Local entrepreneurship, not just big IT, will drive next wave of distributed AI work

While global corporations setting up GCCs in India continue to express confidence in availability of skilled AI engineers, the panel argued that India’s real challenge lies elsewhere.

Drone manufacturer ideaForge wins orders worth over Rs 100 crore from Army

ideaForge has formed a joint venture to manufacture and market UAVs in the US. Its Q6 UAV is now included in NATO and allied procurement systems.

INDIA has a Congress-sized hole. And the fix begins with a little humility

Without a Congress revival, there can be no challenge to the BJP pan-nationally. Modi’s party is growing, and almost entirely at the cost of the Congress.